Literature DB >> 18820814

[Atherosclerotic risk factors associated with cardiorespiratory fitness and BMI in adolescents].

Antonio Stabelini Neto1, Rodrigo Bozza, Anderson Zampier Ulbrich, Italo Quenni A de Vasconcelos, Luis P G Mascarenhas, Margaret C da S Boguszewski, Wagner de Campos.   

Abstract

Previous research has demonstrated high prevalence of atherosclerotic risk factors in adolescents; however, the associate factors related to its onset are unclear. Therefore, the objective of this study was to relate inadequate blood pressure levels, total cholesterol (TC), HDL-C, LDL-C and triglycerides (TG) with different VO2máx and BMI levels in a sample of 249 adolescents, aged between 12 to 16 years old. For VO2máx prediction, the 20 meters test was used. The BMI was calculated using the body mass/heigh(2) equation. The considerate inadequate levels were: blood pressure > or =90th percentile; total cholesterol > or =150 mg/dL; LDL-C > or = 100 mg/dL, TG > or =100 mg/dL and HDL-C <45 mg/dL. Logistic regression was used as statistical procedures, with p<0.05. For the boys, significant associations were observed between the low VO2máx with TC (OR 4.33; IC=1.23-15.20) and TG (OR=4.88; IC=1.15-20.79) and between overweight and TG (OR=4.33; IC=1.42-13.21). After BMI correction, the males subjects with low VO2máx maintained their significant associations with TC (OR=5.73; IC=1.52-21.58) and TG (OR=3.81; IC=1.86-16.94). The evidences in this study suggested an inverse relationship of the cardiorespiratory fitness with TC and TG for boys, independently of the BMI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820814     DOI: 10.1590/s0004-27302008000600014

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  1 in total

1.  High Blood Pressure in Adolescents of Curitiba: Prevalence and Associated Factors.

Authors:  Rodrigo Bozza; Wagner de Campos; Valter Cordeiro Barbosa Filho; Antonio Stabelini Neto; Michael Pereira da Silva; Renato Silva Barbosa Maziero
Journal:  Arq Bras Cardiol       Date:  2016-04-05       Impact factor: 2.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.